Cargando…
Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic
Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been categorized as a highly vulnerable population to COVID...
Autores principales: | Hasan, Sana, Cecilia Lansang, M., Salman Khan, Mohammad, Dasenbrook, Elliot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942190/ https://www.ncbi.nlm.nih.gov/pubmed/33723506 http://dx.doi.org/10.1016/j.jcte.2021.100253 |
Ejemplares similares
-
The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
por: Hasan, Sana, et al.
Publicado: (2022) -
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021) -
Integrating Primary Care into the Management of Cystic
Fibrosis
por: Auth, Roger, et al.
Publicado: (2023) -
The role of modulators in cystic fibrosis related diabetes
por: Merjaneh, Lina, et al.
Publicado: (2021) -
Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future()
por: Sawicki, Gregory S., et al.
Publicado: (2021)